A 2026 study in Biomedical Reports asks a question that rarely gets its own study: why do some people - especially women - get fatty liver without being overweight or obese? In 139 adult female volunteers, the researchers screened a panel of gut-pancreatic hormones and found that age and serum des-acyl ghrelin were the primary determinants of MASLD, with BMI and waist circumference as mediators. The finding is a reminder that the disease is metabolic, not just a matter of weight.
The des-acyl ghrelin detail is the part worth slowing down for. Ghrelin is usually described as the hunger hormone, but des-acyl ghrelin is its de-acylated form, and it does not simply track with hunger. The study found it tracking with MASLD and metabolic abnormalities in women who looked metabolically unremarkable - which is exactly the population that gets missed when the disease is assumed to belong to people with visible weight problems.
Why normal-weight MASLD gets missed
The clinical reality the study names is that many MASLD patients, particularly women, are neither obese nor overweight. When the disease is assumed to track with the scale, the normal-weight patient gets no liver check, and the disease advances quietly. The study’s contribution is a marker - des-acyl ghrelin - that might flag risk in that population, and it is honest about the caveat: this is a cross-sectional study, and longitudinal confirmation is still needed.
The age association is the second signal, and it matters because it names a curve rather than a threshold. MASLD risk rose with age in this female cohort, which fits the broader epidemiology - the disease tracks the cumulative metabolic environment, and years of that environment add up even without a dramatic weight problem.
The food side for the normal-weight reader
The useful part for a reader is that the plate does not wait for a weight problem to matter. The Recommended column - salmon, legumes, whole grains, olive oil, vegetables - is the same pattern that manages liver fat regardless of BMI, and a normal-weight reader has no reason to wait for a scale change to adopt it. The database rates the food, not the body size.
The specific numbers make it concrete. Rolled oats sit in Recommended at about 10 grams of fiber per 100 grams; fatty fish like salmon rate Recommended at roughly 1.3 grams of saturated fat per 100 grams with omega-3s; olive oil and walnuts bring the unsaturated fat. These are the foods that keep the metabolic environment favorable even when the scale says nothing is wrong.
How our editorial team read this
We read this study carefully because the normal-weight angle is exactly where a food site can overcorrect - either dismissing the finding or turning a cross-sectional signal into a warning. Our data editor verified the cohort size, the hormone finding, and the cross-sectional design, and we kept the claims at the level the authors use: a predictive signal, awaiting longitudinal confirmation.
What we did do is connect the finding to the plate for the reader who needs it most - the normal-weight reader who assumed the liver conversation did not apply. The honest line is that the disease is metabolic, the marker is a research signal, and the Recommended column is the part a reader controls today.
The practical takeaway
For a woman with normal weight and metabolic concerns, the ghrelin study is a reminder that the liver conversation does not require a weight problem - the plate manages the metabolic environment either way, and the Recommended column is the daily version. The database covers the food; the clinic covers the markers; the reader owns the pattern.